Backs FY25 revenue view $61B-$64B, consensus $62.92B.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Financial Outlook: Hold Rating Amidst Short-Term Challenges and Long-Term Potential
- Notable companies reporting before tomorrow’s open
- Pfizer call volume above normal and directionally bullish
- Eli Lilly, Pfizer, Amgen – Trump’s 25% Pharma Tariffs Could Drain $51B Annually
- ‘Regulatory Headwinds Set to Bite,’ Says Top Analyst on Novavax Stock (NVAX)